Vitamin D Testing Market Segment Overview, Analysis and Forecast 2023 to 2033

In 2023, the Vitamin D Testing market size is anticipated to be worth US$ 917.55 million. The market is predicted to develop at an 8.1% CAGR to reach US$ 1,999.35 million by 2033, according to Future Market Insights.

Vitamin D testing kits have become much more precise and useful as technology has advanced. These assays, which require only a little blood sample, are widely accessible and may accurately assess the body's vitamin D levels. Because of the development of immunoassay-based technologies that can discriminate between vitamin D2 and D3 forms, the use of Vitamin D Testing kits has expanded.

Technology has made it possible to test vitamin levels at home. With the advent of new technology, it is now possible to develop quick Vitamin D Testing that is both very reliable and simple to use at home. The combination of growing awareness of the importance of vitamin D and the availability of accurate quick vitamin D testing is largely responsible for the favourable market forecast.

Efforts by the government and the private sector to raise awareness of vitamin D deficiency are improving public understanding of vitamin D. Its nutritional benefits and utilisation of Vitamin D Testing processes are boosting the industry even further. Horlicks Women's Plus and Apollo Clinic, for example, teamed together in January 2022 to improve women's awareness of bone health.

Key Players

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • BIOMÉRIEUX
  • Thermo Fisher Scientific Inc.
  • Danaher
  • Siemens Healthineers AG
  • DiaSorin S.p.A.
  • Beckman Coulter, Inc. (BD)
  • Tosoh Bioscience, Inc.
  • Quest Diagnostics Incorporated.

Browse Detail Summary@ https://www.futuremarketinsights.com/reports/vitamin-d-testing-market

Key Segments:

Vitamin D Testing By Product:

  • 25-Hydroxy Vitamin D Testing
  • 1,25-Dihydroxy Vitamin D Testing

Vitamin D Testing by Indication:

  • Vitamin D Testing for Osteoporosis
  • Vitamin D Testing for Rickets
  • Vitamin D Testing for Thyroid Disorders
  • Vitamin D Testing for Vitamin D Deficiency
  • Others

Vitamin D Testing by Technology:

  • Radioimmunoassay
  • ELISA
  • HPLC
  • LC-MS
  • Others

Vitamin D Testing by Patient:

  • Vitamin D Testing in Adult
  • Vitamin D Testing in Pediatric

Vitamin D Testing by Test Location:

  • Vitamin D Testing at Point-of-Care
  • Others

Vitamin D Testing by End-use:

  • Vitamin D Testing for Hospitals
  • Vitamin D Testing for Diagnostic Laboratories
  • Vitamin D Testing for Homecare
  • Others

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more